Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Day One Biopharmaceuticals
Day One Biopharmaceuticals
(DAWN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tovorafenib
neoplasms
,
glioma
,
colorectal neoplasms
,
pancreatic neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
astrocytoma
,
mutation rate
,
carcinoma
,
urinary bladder neoplasms
,
adenocarcinoma
,
papillary thyroid cancer
,
acinar cell carcinoma
,
craniopharyngioma
,
adamantinoma
Bevifimod
type 2 diabetes mellitus
PIMASERTIB
hepatocellular carcinoma
,
liver neoplasms
,
astrocytoma
,
mutation rate
,
neoplasms
,
melanoma
,
neoplasm metastasis
,
non-small-cell lung carcinoma
,
colorectal neoplasms
,
hematologic neoplasms
,
breast neoplasms
,
skin neoplasms
,
cutaneous malignant melanoma
,
pancreatic neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
lung neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
Globulin, immune
healthy volunteers/patients
,
atopic dermatitis
,
dermatitis
,
eczema
,
psoriasis
Histone-arginine methyltransferase carm1
migraine disorders
Surlorian
human influenza
,
influenza in birds
,
h5n1 subtype influenza a virus
,
disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use